rate contract of blood products medicines , for group g (blood products) , albumin (human) 20 % 50 ml. , albumin (human) 20 % 100 ml. , anti rabies serum 300 i.u. per ml , human albumin 20% low salt (sodium content consistently should be less than 80 mmol/l) 50ml infusion , human albumin 20% low salt (sodium content consistently should be less than 80 mmol/l) 100ml infusion , anti gas gangrene serum 30,000 i.u. , anti snake venom serum i.p. lyophilized (polyvalent) 10ml dry , anti thymocite globulin 250mg/5ml (5ml vial) , factor ix complex 500 i.u. lypholised , factor viia(recombinant ) 1mg, powder & solvent for solution for injection , factor viia(recombinant )2mg, powder & solvent for solution for injection , anti-hemophilia clotting factor viii ; recombinant lyophilized injection for human use, in vial containing 250iu/vial , anti-hemophilia clotting factor viii ; recombinant lyophilized injection for human use, in vial containing500iu / vial , anti-hemophilia clotting factor viii ; recombinant lyophilized injection for human use, in vial containing1000iu / vial , hepatitis-b immuno globulin (human) 100 i.u.(1ml vial) , hepatitis-b immuno globulin (human) 200 i.u. (1ml vial) , hepatitis-b vaccine 20 mcg. (surface- antigen protein) (genetically engineered) 200 mcg/ ml (1 ml vial) , hib ( hemophylus type b conjugated vaccine) single dose, freeze dried , hemostatic matrix containing gelatin in pfs thrombin & calcium chloride 10ml pack , igm enriched i.v. immunoglobulin containing igg 76 %, iga 12 % , igm 12% 100ml , ivig 10% 100ml (human normal immunoglobulin ) for iv , ivig 10% 50ml (human normal immunoglobulin ) for iv , ivig 5% 100ml (human normal immunoglobulin ) for iv , influenza vaccine quadrivalant 0.5ml , meningococcal polysaccharide vaccine single dose of 0.5ml , pneumococcal vaccine 23 valent polysaccharide polyvalent 0.5ml , pneumococcal vaccine 13 valent polysaccharide polyvalent 0.5ml , rabies immuno globulin (human) 150 iu / ml, (2 ml pack) , rho (d) immuno globulin (human) 300mcg im , rho (d) immuno globulin (human) 300mcg iv , tetanus immuno globulin (human) 250 iu / single dose , tetanus immuno globulin (human) 500 iu / single dose , tetanus toxid= 5 lf per 0.5 ml multi dose , tetanus toxid= 5 lf per 0.5 ml single dose , typhoid vi conjugate vaccine: each dose of 0.5ml contains: purified vi capsular polysaccharide of salmonella typhi ty2 conjugated to tetanus toxoid - 25 ?g, sodium chloride ip - 4.5 mg, route of administration, im, 0.5ml vial , varicella vaccine 0.5ml (1350 pfu/0.5ml ) single dose , yellow fever vaccine 5/10 doses (0.5ml dose) 2.5ml amp. , 4-factor prothrombin complex concentrate (4f-pcc) 500iu , anti diphtheria serum 10,000 iu , inj. r anti-d 300mg vial /pfs i/m , human prothrombin complex 250u , turoctocog alfa pegol (glycopegylated ehl fviii) 500u , turoctocog alfa pegol (glycopegylated ehl fviii) 1000u , turoctocog alfa pegol (glycopegylated ehl fviii) 1500u , turoctocog alfa pegol (glycopegylated ehl fviii) 2000u , nonacog beta pegol (glycopegylated ehl fix) 500u , nonacog beta pegol (glycopegylated ehl fix) 1000u , nonacog beta pegol (glycopegylated ehl fix) 2000u , feiba (anti-inhibitor coagulant complex) 500u , feiba (anti-inhibitor coagulant complex) 1000u , hepatitis b immunoglobulin 540iu/3ml vial , hepatitis b immunoglobulin 180iu/1ml , recombinant rabies human monoclonal antibody100 iu (2.5 ml per vial) , recombinant rabies human monoclonal antibody 250 iu (2.5ml per vial) , inj. fibrinogen concentrate 1gm , quadrivalent human papilloma virus (serotypes 6,11,16 & 18) vaccine (recombinant) 1ml vial